key: cord-0732594-m6rgchja
authors: Jones, Tristan; Marimuthu, Kalisvar; Bearman, Gonzalo
title: Virtual Infection Prevention and Control in Low- and Middle-Income Countries
date: 2022-02-01
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2022.01.065
sha: e889dca4dc1e0503d6798c6f4e0d96a0add8d082
doc_id: 732594
cord_uid: m6rgchja

COVID-19 brought new challenges and opportunities for infection prevention and control. Virtual infection prevention and control (VIPC), while nascent, is rapidly becoming a viable and necessary strategy for combatting this pandemic. Benefits of VIPC include extending the impact of globally scarce infectious disease providers and public health practitioners, allowing coordination between disparate professionals to more effectively combat infectious disease, and increasing access to and quality of healthcare. While mainly applied in developed countries, VIPC may play its greatest role in low- and middle-income countries (LMICs) with fewer healthcare resources. We conducted a brief literature search of VIPC in LMICs and found that many studies describe solutions in developed countries or describe planned or theoretical solutions. Few studies describe actual VIPC implementation in LMICs, with the exception of China. Literature from related fields, e.g. virtual critical care, and from developed countries is more robust and provides a roadmap for future research on VIPC in LMICs. Further research into strategies and outcomes related to VIPC in LMICs is necessary.

more robust and provides a roadmap for future research on VIPC in LMICs. Further research into strategies and outcomes related to VIPC in LMICs is necessary.

The COVID-19 pandemic brought unprecedented challenges and opportunities to infection prevention and control (IPC) efforts globally. It has spurred healthcare workers and healthcare systems to implement new technologies and strategies for IPC. Virtual infection prevention and control (VIPC) refers to the technologies and strategies separated geographically or temporally from the point of medical care to control the spread of contagious diseases. While a new field, VIPC has been rapidly employed in a variety of contexts over the course of the pandemic as healthcare providers adapted to and innovated in the changing IPC landscape. Many of the new techniques were implemented in developed nations with wellfunded healthcare systems, advanced technological infrastructure, and individual-level access to technology and equipment. Low-and middle-income countries (LMICs) have also experimented with VIPC during the pandemic. VIPC may have greater impact in these nations because they have less well-developed healthcare systems and fewer resources to devote to IPC. As the urgency and severity of this pandemic wane, VIPC will remain a viable tool for such countries to advance IPC.

VIPC provides multiple benefits, particularly in resource-limited settings. First, the COVID-19 pandemic demonstrated the scarcity of infectious disease doctors, epidemiologists, and public health officials globally (Walensky et al., 2020; Williams et al., 2020) . Professionals from a wide swathe of public health and infectious disease fields were reallocated to combat COVID-19, further exacerbating shortages in IPC for other diseases. This is a known problem in developed nations such as the US, and likely worse in LMICs. Several reasons for this include reimbursement regimes that devalue infectious disease and public health work, governmental and charitable disinterest in funding a largely preventative field with a long investment horizon, and for-profit health systems that largely fail to reward preventative strategies such as vaccines. Often these issues are exacerbated for LMICs as resources are more limited and healthcare systems tend to be more privately funded than in developed countries (OECD, 2021) .

Second, VIPC is important because it allows fast and geographically remote communication. Many LMICs have rapidly gained access to digital communication technologies, from instant messaging to smartphones, that allow for easy communication. As pandemics are by definition global, so the response needs to be global as well. International networks of epidemiologists and infectious disease providers are much more effective than siloed teams.

The pandemic likely would have been much worse had not professionals in the first-affected areas rapidly disseminated information on preventing the spread of SARS-CoV-2 both within healthcare systems and in public settings. For example, the determination that the virus could spread via airborne particles resulted in rapid uptake of mask-wearing globally, and the early publication of the genetic sequence allowed rapid rollout of test kits. Moving beyond the immediate pandemic, VIPC will remain important as global issues such as antimicrobial resistance worsen and require effective, decentralized teams of providers around the globe.

Third, VIPC is easily integrated with telehealth, defined as "the use of telecommunications and information technology to provide access to health assessment, diagnosis, intervention, consultation, supervision and information across distance" (Keyser and Baumrucker, 2020) . The same technologies and strategies are often used to communicate with patients, the public, and healthcare providers. Telehealth, in its infancy prior to the pandemic, has rapidly grown and expanded and will remain a fixture in healthcare systems going forward.

Telehealth can provide better healthcare-increasing accessibility through virtual provider visits, and improving quality, in the case of digital apps to better diagnose illness-than traditional healthcare delivery systems. Artificial intelligence (AI) can augment and enhance some of these technologies. However, some attributes, such as easier access to healthcare providers, better patient access to health information via the internet, and the ever-expanding volume of personal health data, run the risk of overburdening already stressed healthcare systems. IPC programs already suffer from underfunding and limited resources for monitoring, data processing, outreach, and education. VIPC provides a possible solution to this problem by extending the reach or impact of infection control practitioners, and allowing remote providers and technologies to relieve local burden in LMICs.

Current literature on VIPC is limited. A PubMed search in August, 2020 using the Medical Subject Headings (MeSH) terms "remote consultation", "remote sensing technology", "telemedicine", or "online systems" combined with "infection control" or "infection control practitioners" yielded 320 published articles, 11 of which described VIPC efforts (Table 1) . Pryor et al. (2021) describe potential VIPC applications in the United States (US), including using AI, in this case machine learning, to better characterize emerging epidemiologic threats. The authors advocate for smarter use of the vast data contained in electronic medical records to better surveil for hospital-acquired infections (HAIs) (Pryor et al., 2021) . A referenced example, the Duke Infection Control Outreach Network, demonstrates the efficacy of a formalized VIPC network in the US (Anderson et al., 2011) . The program provides community hospitals with access to remote hospital epidemiologists and infection preventionists at an academic institution, with associated monthly visits, data analysis and feedback, focused strategies to reduce infection rates, outbreak investigation, and educational programs. By using these combined virtual and non-virtual methods the program reduced rates of HAIs by approximately 50% in participating community hospitals over the seven years studied. Kalhori et al. (2021) conduct a search for digital solutions for combatting COVID-19 in mostly developed nations, including only the US, China, and countries in Western Europe. They describe six categories of methods: telemedicine services, digital learning packages, locationbased tracking, mobile apps, clinical decision support systems, and social media. While some of these rely on digital infrastructure, all could potentially be implemented in LMICs at reasonable cost. Notably, 11 of the 32 mentioned studies are from China, though most are not related specifically to VIPC but rather digital solutions more broadly. Several studies describe a VIPC method of using smartphone applications to track exposures, though none have quantitative results of outcomes (Kamel Boulos and Geraghty, 2020; Pan et al., 2020; Pan, 2020) . One such study specifically described using AI to better characterize disease transmission patterns to help predict and prevent outbreaks at the regional or even hospital level (Gong et al., 2020) . It may be notable that China has been largely successful in pandemic-mitigation efforts, though it remains unknown if this is related to VIPC and the other digital solutions mentioned in this paper or to other factors. Importantly, Kalhori et al. reference only studies of solutions that have been implemented during this pandemic rather than theoretical or planned solutions. Scott et al. (2020) describe several solutions related to VIPC but with respect to critical care medicine. They outline a national strategy for extending the impact of the limited number of critical care providers in the US, a roadmap that could be adapted for infectious disease providers and VIPC. One notable piece of the strategy is telementoring, where an expert physician (e.g. an intensivist) provides guidance to a geographically separated group of frontline, less-specialized healthcare workers, for instance non-intensivist physicians or advanced practice providers. Bundled with other remote technologies and tools such as remote monitoring and AI, a small group of providers can have a disproportionate impact. Ramnath et al. (2021) describe an actual cross-border telemedicine intensive care unit between the US and Mexico.

Other VIPC strategies described in the literature vary from randomized-controlled trials to compiled expert recommendations to perspectives on implementation of possible future technologies. The feasibility of using remote monitoring of patients with tracking apps, including location-enabled apps with daily symptom checkers, has been validated in some developed nations (Varsavsky et al., 2020) . A planned study to use mobile-phone messaging to increase hand hygiene compliance in Uganda is an example of VIPC in a LMIC (Mugambe et al., 2021) . This study had not yet been conducted at time of publication. Another paper from sub-Saharan Africa describes how subspecialty care, in this case pediatric cardiology, can use teleconsults and teleradiology to continue providing services (Sokunbi et al., 2020) . A real-world randomized controlled trial of a web-based training module about personal protective equipment from Switzerland could be implemented in LMICs (Suppan et al., 2020) . Theoretical VIPC applications described in the literature include applying AI to radiology images to detect infectious diseases, using robots to disinfect facilities, and using telecommunications to conduct clinical trials (Alwashmi, 2020; Brezing et al., 2020; Khan et al., 2020) .

The COVID-19 pandemic sparked an explosion of telemedicine and early steps at VIPC across the globe. The literature on VIPC has been limited, however, to mostly developed nations, and much of it describes theoretical or planned interventions. The main study that describes implemented solutions is limited to developed nations and China (Kalhori et al., 2021) . The lack of published literature on VIPC in LMICs does not necessarily imply that it is not being studied or implemented in these countries. Further research in this area is warranted.

VIPC will be an important strategy going forward for ending the COVID-19 pandemic and addressing whatever pandemic comes next. VIPC extends the impact of limited providers and healthcare resources using technology and infrastructure that largely already exists around the globe. It may be especially important in LMICs with less health system funding and fewer Some of the literature referenced in this paper describes planned VIPC studies, and it is likely that many more VIPC implementation studies are underway globally. Such studies on VIPC implementation and related outcomes are needed.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

There was no financial support given for the research or preparation of this article

This article complied with all ethical research standards and was exempt from institutional review board approval. Real-world description of a cross-border "Tele-ICU" that provides on-demand individual patient consultations by US intensive care unit specialists to hospitals in Mexico An effective cross-border telemedicine program was established to extend the reach of US-based intensivists Scott et al., 2020 Description of advanced technologies that are possibly helpful with VIPC related to COVID-19: telemedicine and mobile care, tiered telementoring, telecritical care, robotics, and artificial intelligence for monitoring Commentary, no results Sokunbi et al., 2020 Compiled recommendations for keeping specialized cardiology care, including surgery, available to pediatric patients in sub-Saharan Africa during the pandemic, including teleconsultations from experts in developed nations One specialty hospital in Nigeria was able to continue providing necessary care despite the pandemic Suppan et al., 2020 Real-world randomized-controlled trial of a webbased training module for proper personal protective equipment use in Switzerland No significant difference in knowledge of personal protective equipment was found between traditional guideline-based training and a gamified e-learning platform Varsavsky et al., 2020 Real-world validation of a downloadable tracking app with daily questionnaire to study community spread of COVID-19 in the United Kingdom A self-reported symptom checker app had similar detection of SARS-CoV-2 spread as traditional national community surveys

The Use of Digital Health in the Detection and Management of COVID-19

The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network

Digital Clinical Trials for Substance Use Disorders in the Age of Covid-19

Cloud-Based System for Effective Surveillance and Control of COVID-19: Useful Experiences From Hubei

Digital Health Solutions to Control the COVID-19 Pandemic in Countries With High Disease Prevalence: Literature Review

Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics

Medicaid Telehealth Policies in Response to COVID-19

Robotics Utilization for Healthcare Digitization in Global

Impact of mhealth messages and environmental cues on hand hygiene practice among healthcare workers in the greater Kampala metropolitan area, Uganda: study protocol for a cluster randomized trial

Health resources -Health spending -OECD Data

Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases

Application of personal-oriented digital technology in preventing transmission of COVID-19, China

Virtual infection prevention-The next frontier

An In-Person and Telemedicine "Hybrid" System to Improve Cross-Border Critical Care in COVID-19

Advanced Digital Health Technologies for COVID-19 and Future Emergencies

Maintaining paediatric cardiac services during the COVID-19 pandemic in a developing country in sub-Saharan Africa: guidelines for a "scale up" in the face of a global "scale down

Effect of an E-Learning Module on Personal Protective Equipment Proficiency Among Prehospital Personnel: Web-Based Randomized Controlled Trial

Detecting COVID-19 infection hotspots in England using large-scale self-reported data from a mobile application

Where Is the ID in COVID-19?

One Field Epidemiologist per 200,000 Population: Lessons Learned from Implementing a Global Public Health Workforce Target